| Literature DB >> 18594542 |
V Benetou1, A Trichopoulou, P Orfanos, A Naska, P Lagiou, P Boffetta, D Trichopoulos.
Abstract
Adherence to traditional Mediterranean diet (MD) has been reported to be inversely associated with total, as well as cardiovascular, mortality. We have examined the relation between degree of such adherence and incidence of cancer overall in a general population sample of 25 623 participants (10 582 men, 15 041 women) of the Greek segment of the European Prospective Investigation into Cancer and nutrition (EPIC). All subjects completed a validated, interviewer-administered, semi-quantitative food-frequency questionnaire at enrolment. Degree of adherence to the traditional MD was assessed through a 10-point scale (0 minimal; 9 maximal) that incorporated key dietary characteristics. During a median follow-up of 7.9 years and 188 042 total person-years, 851 medically confirmed incident cancer cases (421 men, 430 women) were recorded. Using proportional hazards regression with adjustment for potential confounders, we found that a higher degree of MD adherence was associated with lower overall cancer incidence. A two-point increase in the score corresponded to a 12% reduction in cancer incidence (adjusted hazard ratio, 0.88 (95% confidence interval 0.80, 0.95)). The association was exposure-dependent and stronger among women. This inverse association with MD adherence was considerably stronger than that predicted on the basis of the associations of the individual components of this diet and points to the value of analysing dietary patterns in cancer studies.Entities:
Mesh:
Year: 2008 PMID: 18594542 PMCID: PMC2453039 DOI: 10.1038/sj.bjc.6604418
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Baseline characteristics of 25 623 cohort participants and 851 incident cancer cases, by sex and score in the Mediterranean diet scale: The Greek EPIC Study.
|
|
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||
| Age (years) | 54.1 (13.7) | 64.5 (9.8) | 52.7 (12.7) | 61.7 (9.9) | 52.3 (11.9) | 60.7 (10.2) | 54.2 (13.2) | 58.4 (11.1) | 53.2 (12.3) | 57.9 (11.8) | 52.6 (11.5) | 55.9 (11.4) |
| Formal education (years) | 8.9 (4.8) | 6.6 (3.9) | 9.4 (4.8) | 8.0 (4.9) | 9.9 (4.8) | 8.1 (4.7) | 7.6 (4.7) | 7.0 (4.7) | 8.0 (4.7) | 7.5 (4.6) | 8.7 (5.0) | 8.7 (4.9) |
| Height (cm) | 169.4 (7.4) | 167.4 (7.1) | 169.9 (7.1) | 168.8 (6.6) | 170.4 (7.0) | 169.1 (6.7) | 155.8 (6.6) | 155.4 (6.4) | 156.3 (6.5) | 156.1 (6.3) | 156.9 (6.5) | 156.8 (7.6) |
| Body Mass Index (kg m−2) | 28.0 (3.9) | 27.3 (3.9) | 28.2 (3.8) | 27.9 (3.9) | 28.4 (3.7) | 28.1 (4.1) | 29.1 (5.3) | 29.4 (5.5) | 29.0 (5.2) | 30.2 (5.6) | 28.9 (5.1) | 29.5 (5.7) |
| Physical activity (MET-hours per day) | 34.5 (6.1) | 32.7 (5.5) | 35.4 (6.2) | 33.7 (5.2) | 36.0 (6.5) | 34.5 (6.5) | 34.8 (4.4) | 34.8 (4.0) | 35.6 (4.2) | 35.1 (3.8) | 36.2 (4.1) | 36.4 (4.6) |
|
| ||||||||||||
| | ||||||||||||
| Never | 27 | 20 | 26 | 18 | 24 | 16 | 76 | 79 | 74 | 81 | 73 | 70 |
| Former | 32 | 35 | 35 | 40 | 37 | 46 | 7 | 7 | 8 | 5 | 9 | 11 |
| Current | 41 | 45 | 39 | 42 | 39 | 38 | 17 | 14 | 18 | 14 | 18 | 19 |
| | ||||||||||||
| <10 | 67 | 71 | 49 | 53 | 31 | 39 | 96 | 92 | 91 | 93 | 85 | 88 |
| 10 to <30 | 18 | 15 | 32 | 30 | 46 | 35 | 3 | 6 | 8 | 6 | 14 | 12 |
| ⩾30 | 14 | 14 | 19 | 17 | 23 | 25 | 1 | 2 | 1 | 1 | 1 | 0 |
| | ||||||||||||
| No | 95 | 96 | 95 | 90 | 95 | 96 | 81 | 76 | 82 | 85 | 81 | 77 |
| Yes | 5 | 4 | 5 | 10 | 5 | 4 | 19 | 24 | 18 | 15 | 19 | 23 |
Distribution of incident cancer cases, by major sites, among 25 623 men and women (188 042 person-years): The Greek EPIC Study.
|
|
|
|
|
|---|---|---|---|
| Stomach | C16 | 35 | 13 |
| Large bowel | C18-21 | 38 | 38 |
| Liver | C22 | 19 | 9 |
| Pancreas | C25 | 18 | 17 |
| Lung | C34 | 116 | 19 |
| Hematopoietic system | C42 | 25 | 18 |
| Breast | C50 | 0 | 158 |
| Cervix uteri | C53 | — | 21 |
| Corpus uteri | C54 | — | 15 |
| Ovary | C56 | — | 34 |
| Prostate | C61 | 48 | — |
| Kidney | C64 | 15 | 7 |
| Bladder | C67 | 27 | 9 |
| Brain | C71 | 11 | 14 |
| Thyroid gland | C73 | 2 | 13 |
| Lymphomas | C77 | 16 | 15 |
| All other sites | 50 | 30 | |
| Total | 421 | 430 |
*World Health Organization (1990).
Mean daily intake (±s.d.) of selected dietary variables and associated hazard ratios for incident cancer per indicated increments of intake with 95% confidence intervals (CI): The Greek EPIC Study.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Vegetables | 578.6±232.6 | 531.1±231.8 | 230 | 0.96 | 0.88–1.05 |
| Legumes | 10.2±7.3 | 7.8±5.7 | 6 | 0.98 | 0.92–1.05 |
| Fruits – including nuts | 383.2±214.5 | 375.6±206.7 | 205 | 1.01 | 0.93–1.09 |
| Dairy products | 221.2±147.2 | 214.7±146.0 | 140 | 1.03 | 0.96–1.10 |
| Cereals | 187.2±79.9 | 144.6±55.3 | 60 | 0.98 | 0.91–1.05 |
| Meat | 126.2±60.7 | 93.7±44.7 | 50 | 1.08 | 0.99–1.17 |
| Fish | 26.3±20.0 | 21.8±15.7 | 15 | 1.03 | 0.99–1.08 |
| Ratio of monounsaturated to saturated lipids | 1.8±0.5 | 1.8±0.5 | 0.5 | 0.91 | 0.85–0.98 |
| Ethanol | 18.0±23.9 | 3.3±6.2 | 10 | 1.00 | 0.96–1.04 |
| Monounsaturated lipids | 57.1±20.1 | 47.9±17.8 | 18 | 1.02 | 0.92–1.13 |
| Saturated lipids | 33.6±13.3 | 28.0±11.6 | 10 | 1.09 | 0.99–1.19 |
| Polyunsaturated lipids | 17.2±9.1 | 14.8±8.2 | 7 | 1.04 | 0.98–1.11 |
| Olive oil | 52.0±24.1 | 44.3±21.9 | 20 | 0.97 | 0.91–1.04 |
| Potatoes | 94.9±62.4 | 71.7±47.5 | 50 | 1.03 | 0.95–1.11 |
| Eggs | 18.3±13.1 | 15.3±10.2 | 10 | 1.07 | 1.01–1.13 |
| Confectionery | 25.3±19.8 | 22.4±17.5 | 15 | 1.01 | 0.95–1.08 |
| Nonalcoholic beverages | 376.0±243.3 | 285.8±200.6 | 220 | 0.99 | 0.91–1.08 |
| Energy intake (kcal day−1) | 2377±721 | 1898±580 | 650 | 1.05 | 0.98–1.14 |
A round number close to the s.d. of the daily intake of the respective dietary variable.
Stratified by sex. Adjusted for age (<35, 35–44, 45–54, 55–64, and ⩾65 years; categorically), years of schooling (⩽5, 6–11, 12, and ⩾13; categorically), smoking status (never smoker, former smoker, and five categories of current smoker: 1–10, 11–20, 21–30, 31–40, and ⩾41 cigarettes per day; ordered), body mass index (in ordered quintiles), height (in ordered quintiles), physical activity (MET-hours per day; in ordered quintiles), ethanol intake (per 10 grams; continuously), supplement use (no, yes) and total energy intake (in ordered quintiles) except for the model for energy intake.
Hazard ratiosa for incident cancer (95% confidence intervals) by score in the Mediterranean Diet Scale among 25 623 cohort participants: The Greek EPIC Study.
|
| ||||
|---|---|---|---|---|
|
|
|
|
|
|
|
| Reference | 0.84 (0.72–0.98) | 0.78 (0.64–0.94) | 0.88 (0.80–0.95) |
| Smoking-related cancers | Reference | 0.83 (0.67–1.03) | 0.86 (0.66–1.11) | 0.91 (0.81–1.02) |
| Smoking-unrelated cancers | Reference | 0.86 (0.68–1.08) | 0.70 (0.52–0.93) | 0.84 (0.74–0.95) |
| Excluding first year of follow-up (all cancers) | Reference | 0.85 (0.72–1.00) | 0.76 (0.63–0.93) | 0.88 (0.80–0.96) |
|
| ||||
| Men | Reference | 0.96 (0.76–1.20) | 0.83 (0.63–1.09) | 0.91 (0.80–1.02) |
| Women | Reference | 0.74 (0.59–0.92) | 0.73 (0.56–0.96) | 0.84 (0.74–0.95) |
Stratified by sex, where applicable. Adjusted for age (<35, 35–44, 45–54, 55–64, and ⩾65 years; categorically), years of schooling (⩽5, 6–11, 12, and ⩾13; categorically), smoking status (never smoker, former smoker, and five categories of current smoker: 1–10, 11–20, 21–30, 31–40, and ⩾41 cigarettes per day; ordered), body mass index (in ordered quintiles), height (in ordered quintiles), physical activity (MET-hours per day; in ordered quintiles), supplement use (no, yes), total energy intake (in ordered quintiles), as well as consumption of potatoes, eggs, confectionary, and non alcoholic beverages (per increment defined in Table 3).
454 cases of tobacco-related cancer sites (stomach, liver, pancreas, lung, hematopoietic system, cervix uteri, kidney, bladder, other sites).
397 cases for tobacco-unrelated cancer sites (large bowel, breast, corpus uteri, ovary, prostate, brain, thyroid gland, lymphomas).